Upcoming free, educational webinars from Xtalks will feature topics on biomarkers, clinical trials, commercialization and HEOR, emerging market, food ingredients and innovations, laboratory technology ...
Opinion
43mOpinion
Open and shut source case: There’s method in Palantir CEO Alex Karp’s ‘mad’ outburst against Big AI overselling corporates
Palantir CEO Alex Karp has fiercely criticized the US AI industry, particularly OpenAI and Anthropic, for their token-based pricing and 'oversold' AI capabilities. This sparks a debate between closed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results